Trial Profile
TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary)
- Indications Liver metastases; Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 10 Aug 2011 New trial record